ReP USP - Resultado da busca

Artigo de periodico
Effect of Lung Recruitment and Titrated Positive End-Expiratory Pressure (PEEP) vs Low PEEP on Mortality in Patients With Acute Respiratory Distress Syndrome: A Randomized Clinical Trial (2017)
Tucci, Mauro Roberto; Hajjar, Ludhmila Abrahão; Galas, Filomena Regina Barbosa Gomes; Borges, Marcos de Carvalho; Carvalho, Carlos Roberto Ribeiro de; Amato, Marcelo Britto Passos
Source: JAMA. Unidades: FM, FMRP
Subjects: ESTUDOS RANDOMIZADOS, SÍNDROME DO DESCONFORTO RESPIRATÓRIO EM ADULTOS, MORTALIDADE, RESPIRAÇÃO ARTIFICIAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TUCCI, Mauro Roberto et al. Effect of Lung Recruitment and Titrated Positive End-Expiratory Pressure (PEEP) vs Low PEEP on Mortality in Patients With Acute Respiratory Distress Syndrome: A Randomized Clinical Trial. JAMA, v. 318, n. 14, p. 1335-1345, 2017Tradução . . Disponível em: https://doi.org/10.1001/jama.2017.14171. Acesso em: 27 jul. 2024.
APA
Tucci, M. R., Hajjar, L. A., Galas, F. R. B. G., Borges, M. de C., Carvalho, C. R. R. de, & Amato, M. B. P. (2017). Effect of Lung Recruitment and Titrated Positive End-Expiratory Pressure (PEEP) vs Low PEEP on Mortality in Patients With Acute Respiratory Distress Syndrome: A Randomized Clinical Trial. JAMA, 318( 14), 1335-1345. doi:10.1001/jama.2017.14171
NLM
Tucci MR, Hajjar LA, Galas FRBG, Borges M de C, Carvalho CRR de, Amato MBP. Effect of Lung Recruitment and Titrated Positive End-Expiratory Pressure (PEEP) vs Low PEEP on Mortality in Patients With Acute Respiratory Distress Syndrome: A Randomized Clinical Trial [Internet]. JAMA. 2017 ; 318( 14): 1335-1345.[citado 2024 jul. 27 ] Available from: https://doi.org/10.1001/jama.2017.14171
Vancouver
Tucci MR, Hajjar LA, Galas FRBG, Borges M de C, Carvalho CRR de, Amato MBP. Effect of Lung Recruitment and Titrated Positive End-Expiratory Pressure (PEEP) vs Low PEEP on Mortality in Patients With Acute Respiratory Distress Syndrome: A Randomized Clinical Trial [Internet]. JAMA. 2017 ; 318( 14): 1335-1345.[citado 2024 jul. 27 ] Available from: https://doi.org/10.1001/jama.2017.14171
Artigo de periodico-carta/editorial
Alternatives in the evaluation of suspected coronary heart disease [letter] (2017)
Bittencourt, Márcio Sommer; Fernandes, Juliano Lara
Source: JAMA. Unidade: HU
Assunto: CORONARIOPATIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BITTENCOURT, Márcio Sommer e FERNANDES, Juliano Lara. Alternatives in the evaluation of suspected coronary heart disease [letter]. JAMA. Chicago: Hospital Universitário, Universidade de São Paulo. Disponível em: https://doi.org/10.1001/jama.2016.18323. Acesso em: 27 jul. 2024. , 2017
APA
Bittencourt, M. S., & Fernandes, J. L. (2017). Alternatives in the evaluation of suspected coronary heart disease [letter]. JAMA. Chicago: Hospital Universitário, Universidade de São Paulo. doi:10.1001/jama.2016.18323
NLM
Bittencourt MS, Fernandes JL. Alternatives in the evaluation of suspected coronary heart disease [letter] [Internet]. JAMA. 2017 ; 317( ja 2017): 211.[citado 2024 jul. 27 ] Available from: https://doi.org/10.1001/jama.2016.18323
Vancouver
Bittencourt MS, Fernandes JL. Alternatives in the evaluation of suspected coronary heart disease [letter] [Internet]. JAMA. 2017 ; 317( ja 2017): 211.[citado 2024 jul. 27 ] Available from: https://doi.org/10.1001/jama.2016.18323
Artigo de periodico
International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis (2006)
Ataíde Junior, Luiz; Atie, Jacob; Avezum, Álvaro; Bandeira, Francisco; Bodanese, Luiz; Brasileiro, Antonio; Carvalho, Antonio Carlos; Esporcatte, Roberto; Esteves, José Péricles; Eugênio, Angela Maria; Feitosa, Gilson; Fernandes, Jefferson; Halpern, Alfredo; Lopes, Cícero; Lyra, Ruy; Machado, Nilton; Maciel, Léa Maria Zanini; Marino, Roberto; Massaro, Ayrton; Matos, Amélio; Mesquita, Evandro; Moreira, Maria; Nagato, Yosio; Nicolau, José Carlos; Nogueira, Paulo Roberto; Pazin-Filho, Antônio; Pires, Marco Tulio; Rocha, Antonio; Rocha, Ricardo; Saraiva, José Francisco; Schmid, Helena; Azul, João Serro; Tambascia, Marcos; Xavier, Sérgio; Yamamoto, Fabio; Yoshida, Winston; Zanella, Maria Tereza
Source: JAMA. Unidade: FMRP
Subjects: DOENÇAS CARDIOVASCULARES, FATORES DE RISCO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ATAÍDE JUNIOR, Luiz et al. International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. JAMA, v. 295, n. 2, p. 180-189, 2006Tradução . . Acesso em: 27 jul. 2024.
APA
Ataíde Junior, L., Atie, J., Avezum, Á., Bandeira, F., Bodanese, L., Brasileiro, A., et al. (2006). International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. JAMA, 295( 2), 180-189.
NLM
Ataíde Junior L, Atie J, Avezum Á, Bandeira F, Bodanese L, Brasileiro A, Carvalho AC, Esporcatte R, Esteves JP, Eugênio AM, Feitosa G, Fernandes J, Halpern A, Lopes C, Lyra R, Machado N, Maciel LMZ, Marino R, Massaro A, Matos A, Mesquita E, Moreira M, Nagato Y, Nicolau JC, Nogueira PR, Pazin-Filho A, Pires MT, Rocha A, Rocha R, Saraiva JF, Schmid H, Azul JS, Tambascia M, Xavier S, Yamamoto F, Yoshida W, Zanella MT. International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. JAMA. 2006 ; 295( 2): 180-189.[citado 2024 jul. 27 ]
Vancouver
Ataíde Junior L, Atie J, Avezum Á, Bandeira F, Bodanese L, Brasileiro A, Carvalho AC, Esporcatte R, Esteves JP, Eugênio AM, Feitosa G, Fernandes J, Halpern A, Lopes C, Lyra R, Machado N, Maciel LMZ, Marino R, Massaro A, Matos A, Mesquita E, Moreira M, Nagato Y, Nicolau JC, Nogueira PR, Pazin-Filho A, Pires MT, Rocha A, Rocha R, Saraiva JF, Schmid H, Azul JS, Tambascia M, Xavier S, Yamamoto F, Yoshida W, Zanella MT. International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. JAMA. 2006 ; 295( 2): 180-189.[citado 2024 jul. 27 ]
Artigo de periodico
Endoscopic ultrasound added to mediastinoscopy for preoperative staging of patients with lung cancer (2005)
Annema, Jouke T.; Versteegh, Michel I.; Veselic, Maud; Welker, Lutz; Mauad, Thais; Sont, Jakob K.; Willems, Luuk N. A.; Rabe, Klaus F.
Source: JAMA. Unidade: FM
Subjects: NEOPLASIAS PULMONARES (ULTRASONOGRAFIA), ENDOSCOPIA, ESTADIAMENTO DE NEOPLASIAS, DIAGNÓSTICO POR IMAGEM, CUIDADOS PÓS-OPERATÓRIOS, SENSIBILIDADE E ESPECIFICIDADE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ANNEMA, Jouke T. et al. Endoscopic ultrasound added to mediastinoscopy for preoperative staging of patients with lung cancer. JAMA, v. 294, n. 8, 2005Tradução . . Acesso em: 27 jul. 2024.
APA
Annema, J. T., Versteegh, M. I., Veselic, M., Welker, L., Mauad, T., Sont, J. K., et al. (2005). Endoscopic ultrasound added to mediastinoscopy for preoperative staging of patients with lung cancer. JAMA, 294( 8).
NLM
Annema JT, Versteegh MI, Veselic M, Welker L, Mauad T, Sont JK, Willems LNA, Rabe KF. Endoscopic ultrasound added to mediastinoscopy for preoperative staging of patients with lung cancer. JAMA. 2005 ; 294( 8):[citado 2024 jul. 27 ]
Vancouver
Annema JT, Versteegh MI, Veselic M, Welker L, Mauad T, Sont JK, Willems LNA, Rabe KF. Endoscopic ultrasound added to mediastinoscopy for preoperative staging of patients with lung cancer. JAMA. 2005 ; 294( 8):[citado 2024 jul. 27 ]
Artigo de periodico
Efficacy and bleeding complications among patients randomized to Enoxaparin or unfractionated heparin for antithrombin therapy in Non-ST-Segment elevation acute coronary syndromes: a systematic overview (2004)
Petersen, John L.; Mahaffey, Kenneth W.; Hasselblad, Vic; Antman, Elliott M.; Cohen, Marc; Goodman, Shaun G.; Langer, Anatoly; Blazing, Michael A.; Le-Moigne-Amrani, Anne; Lemos, James A. de; Nessel, Christopher C.; Harrington, Robert A.; Ferguson, James J.; Braunwald, Eugene; Califf, Robert M.; Marin-Neto, José Antônio
Source: JAMA. Unidade: FMRP
Assunto: INFARTO DO MIOCÁRDIO (TRATAMENTO)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PETERSEN, John L. et al. Efficacy and bleeding complications among patients randomized to Enoxaparin or unfractionated heparin for antithrombin therapy in Non-ST-Segment elevation acute coronary syndromes: a systematic overview. JAMA, v. 292, n. 1, p. 89-96, 2004Tradução . . Disponível em: https://doi.org/10.1016/j.accreview.2004.08.090. Acesso em: 27 jul. 2024.
APA
Petersen, J. L., Mahaffey, K. W., Hasselblad, V., Antman, E. M., Cohen, M., Goodman, S. G., et al. (2004). Efficacy and bleeding complications among patients randomized to Enoxaparin or unfractionated heparin for antithrombin therapy in Non-ST-Segment elevation acute coronary syndromes: a systematic overview. JAMA, 292( 1), 89-96. doi:10.1016/j.accreview.2004.08.090
NLM
Petersen JL, Mahaffey KW, Hasselblad V, Antman EM, Cohen M, Goodman SG, Langer A, Blazing MA, Le-Moigne-Amrani A, Lemos JA de, Nessel CC, Harrington RA, Ferguson JJ, Braunwald E, Califf RM, Marin-Neto JA. Efficacy and bleeding complications among patients randomized to Enoxaparin or unfractionated heparin for antithrombin therapy in Non-ST-Segment elevation acute coronary syndromes: a systematic overview [Internet]. JAMA. 2004 ; 292( 1): 89-96.[citado 2024 jul. 27 ] Available from: https://doi.org/10.1016/j.accreview.2004.08.090
Vancouver
Petersen JL, Mahaffey KW, Hasselblad V, Antman EM, Cohen M, Goodman SG, Langer A, Blazing MA, Le-Moigne-Amrani A, Lemos JA de, Nessel CC, Harrington RA, Ferguson JJ, Braunwald E, Califf RM, Marin-Neto JA. Efficacy and bleeding complications among patients randomized to Enoxaparin or unfractionated heparin for antithrombin therapy in Non-ST-Segment elevation acute coronary syndromes: a systematic overview [Internet]. JAMA. 2004 ; 292( 1): 89-96.[citado 2024 jul. 27 ] Available from: https://doi.org/10.1016/j.accreview.2004.08.090
Artigo de periodico
Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: Phase Z of the A to Z trial (2004)
Lemos, James A.; Blazing, Michael A.; Wiviott, Stephen D.; Lewis, Eldrin F.; Fox, Keith A. A.; White, Harvey D.; Rouleau, Jean-Lucien; Pedersen, Terje; Gardner, Laura H.; Mukherjee, Robin; Ramsey, Karen E.; Palmisano, Joanne; Bilheimer, David W.; Pfeffer, Marc A.; Califf, Robert M.; Braunwald, Eugene; Marin-Neto, José Antônio
Source: JAMA. Unidade: FMRP
Assunto: CORONARIOPATIA (TRATAMENTO)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LEMOS, James A. et al. Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: Phase Z of the A to Z trial. JAMA, v. 292, n. 11, p. 1307-1316, 2004Tradução . . Acesso em: 27 jul. 2024.
APA
Lemos, J. A., Blazing, M. A., Wiviott, S. D., Lewis, E. F., Fox, K. A. A., White, H. D., et al. (2004). Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: Phase Z of the A to Z trial. JAMA, 292( 11), 1307-1316.
NLM
Lemos JA, Blazing MA, Wiviott SD, Lewis EF, Fox KAA, White HD, Rouleau J-L, Pedersen T, Gardner LH, Mukherjee R, Ramsey KE, Palmisano J, Bilheimer DW, Pfeffer MA, Califf RM, Braunwald E, Marin-Neto JA. Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: Phase Z of the A to Z trial. JAMA. 2004 ; 292( 11): 1307-1316.[citado 2024 jul. 27 ]
Vancouver
Lemos JA, Blazing MA, Wiviott SD, Lewis EF, Fox KAA, White HD, Rouleau J-L, Pedersen T, Gardner LH, Mukherjee R, Ramsey KE, Palmisano J, Bilheimer DW, Pfeffer MA, Califf RM, Braunwald E, Marin-Neto JA. Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: Phase Z of the A to Z trial. JAMA. 2004 ; 292( 11): 1307-1316.[citado 2024 jul. 27 ]
Artigo de periodico
Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: Primary results of the SYNERGY randomized trial (2004)
Marin-Neto, José Antônio
Source: JAMA. Unidade: FMRP
Assunto: CORONARIOPATIA (TRATAMENTO)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MARIN-NETO, José Antônio. Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: Primary results of the SYNERGY randomized trial. JAMA, v. 292, n. 1, p. 45-54, 2004Tradução . . Acesso em: 27 jul. 2024.
APA
Marin-Neto, J. A. (2004). Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: Primary results of the SYNERGY randomized trial. JAMA, 292( 1), 45-54.
NLM
Marin-Neto JA. Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: Primary results of the SYNERGY randomized trial. JAMA. 2004 ; 292( 1): 45-54.[citado 2024 jul. 27 ]
Vancouver
Marin-Neto JA. Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: Primary results of the SYNERGY randomized trial. JAMA. 2004 ; 292( 1): 45-54.[citado 2024 jul. 27 ]
Artigo de periodico
Safety and efficacy of enoxaparin vs unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes who receive tirofiban and aspirin: A randomized controlled trial (2004)
Blazing, Michael A.; Lemos, James A. de; White, Harvey; Fox, Keith A. A.; Verheugt, Freek W. A.; Ardissino, Diego; DiBattiste, Peter M.; Palmisano, Joanne; Bilheimer, David W.; Snapinn, Steven M.; Ramsey, Karen E.; Gardner, Laura H.; Hasselblad, Vic; Pfeffer, Marc A.; Lewis, Eldrin F.; Braunwald, Eugene; Califf, Robert M.; Marin-Neto, José Antônio
Source: JAMA. Unidade: FMRP
Subjects: INFARTO DO MIOCÁRDIO (TRATAMENTO), ISQUEMIA MIOCÁRDICA (TRATAMENTO)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BLAZING, Michael A. et al. Safety and efficacy of enoxaparin vs unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes who receive tirofiban and aspirin: A randomized controlled trial. JAMA, 2004Tradução . . Acesso em: 27 jul. 2024.
APA
Blazing, M. A., Lemos, J. A. de, White, H., Fox, K. A. A., Verheugt, F. W. A., Ardissino, D., et al. (2004). Safety and efficacy of enoxaparin vs unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes who receive tirofiban and aspirin: A randomized controlled trial. JAMA.
NLM
Blazing MA, Lemos JA de, White H, Fox KAA, Verheugt FWA, Ardissino D, DiBattiste PM, Palmisano J, Bilheimer DW, Snapinn SM, Ramsey KE, Gardner LH, Hasselblad V, Pfeffer MA, Lewis EF, Braunwald E, Califf RM, Marin-Neto JA. Safety and efficacy of enoxaparin vs unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes who receive tirofiban and aspirin: A randomized controlled trial. JAMA. 2004 ;[citado 2024 jul. 27 ]
Vancouver
Blazing MA, Lemos JA de, White H, Fox KAA, Verheugt FWA, Ardissino D, DiBattiste PM, Palmisano J, Bilheimer DW, Snapinn SM, Ramsey KE, Gardner LH, Hasselblad V, Pfeffer MA, Lewis EF, Braunwald E, Califf RM, Marin-Neto JA. Safety and efficacy of enoxaparin vs unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes who receive tirofiban and aspirin: A randomized controlled trial. JAMA. 2004 ;[citado 2024 jul. 27 ]

USP Schools

ReP

Filtros

Authors

USP affiliated authors

Subjects

Indexado em